Affordable Access

Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy.

Authors
Type
Published Article
Journal
Experimental Hematology
0301-472X
Publisher
Elsevier
Publication Date
Volume
35
Issue
7
Pages
1069–1073
Identifiers
PMID: 17588475
Source
Medline

Abstract

Daily divided dosing of deferasirox changes the relative cardiac and liver iron chelation profile compared with daily single dosing, trading improvements in cardiac iron elimination for less-effective hepatic chelation.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments